國立虎尾科技大學 |

Radiopharmaceuticals for therapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Radiopharmaceuticals for therapy/ by F. F. (Russ) Knapp, Ashutosh Dash.
Author:	Knapp, F. F. (Russ)
other author:	Dash, Ashutosh.
Published:	New Delhi :Springer India : : 2016.,
Description:	xxiv, 347 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Radiopharmaceuticals. -
Online resource:	http://dx.doi.org/10.1007/978-81-322-2607-9
ISBN:	9788132226079

Radiopharmaceuticals for therapy
Knapp, F. F. (Russ)

Radiopharmaceuticals for therapy[electronic resource] /by F. F. (Russ) Knapp, Ashutosh Dash. - New Delhi :Springer India :2016. - xxiv, 347 p. :ill., digital ;24 cm.

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.

ISBN: 9788132226079

Standard No.: 10.1007/978-81-322-2607-9doiSubjects--Topical Terms:

895487
Radiopharmaceuticals.

LC Class. No.: RS431.R34

Dewey Class. No.: 615.842

Radiopharmaceuticals for therapy
LDR:02382nam a2200301 a 4500 001 862284
003 DE-He213
005 20160817155819.0
006 m d
007 cr nn 008maaau
008 170720s2016 ii s 0 eng d
020 $a 9788132226079 $q (electronic bk.)
020 $a 9788132226062 $q (paper)
024 7 $a 10.1007/978-81-322-2607-9 $2 doi
035 $a 978-81-322-2607-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.R34
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 615.842 $2 23
090 $a RS431.R34 $b K67 2016
100 1 $a Knapp, F. F. (Russ) $3 1105543
245 1 0 $a Radiopharmaceuticals for therapy $h [electronic resource] / $c by F. F. (Russ) Knapp, Ashutosh Dash.
260 $a New Delhi : $c 2016. $b Springer India : $b Imprint: Springer,
300 $a xxiv, 347 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650 0 $a Radiopharmaceuticals. $3 895487
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Pharmacotherapy. $3 973587
650 2 4 $a Oncology. $3 593951
650 2 4 $a Endocrinology. $3 645497
700 1 $a Dash, Ashutosh. $3 1105544
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-81-322-2607-9
950 $a Medicine (Springer-11650)